Why the study?
The study aimed to enhance prehospital risk assessment for suspected NSTE-ACS patients by incorporating point-of-care high-sensitivity cardiac troponin devices into a modified HEART-score.
Does a modified HEART-score using high-sensitivity cardiac troponin improve risk stratification for major adverse cardiac events in patients suspected of NSTE-ACS?
Does a modified HEART-score using high-sensitivity cardiac troponin improve risk stratification for major adverse cardiac events in patients suspected of NSTE-ACS?
A modified HEART-score incorporating high-sensitivity troponin cut-offs improves sensitivity and negative predictive value for safely ruling out NSTE-ACS in the prehospital setting.
Answers are grounded in this paper and cite their sources.
Modified HEART-score with POC hs-cTn may refine prehospital NSTE-ACS stratification; leaves open superiority pending prospective validation.
Aim: This study aims to enhance prehospital risk assessment for suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) patients using the HEART-score. By incorporating novel point-of-care high-sensitivity cardiac troponin devices, a modified HEART-score was developed and compared with the conventional approach. Patients & methods: Troponin points within the modified HEART-score are based on values below the limit of quantitation (LoQ), between the LoQ and 99th percentile and above the 99th percentile of the used device. A total HEART-score of three or lower is considered low-risk for major adverse cardiac events. Results & conclusion: The number of low-risk patients decreased based on the modified HEART-score. The sensitivity and negative predictive value increased which suggests increasing safety in ruling out patients with suspected NSTE-ACS.
No takes yet. Share an insight, caveat, or question.
Tolsma et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: